The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.
The Funding Opportunity Announcement (FOA) aims to support the development and implementation of early to late-stage clinical trials for interventions targeting cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) as well as Alzheimer's disease-related Dementias (ADRD). This includes research across all stages of the disease from pre-symptomatic to more severe stages. Additionally, the grant encourages studies that seek to improve trial design and methods for these interventions.